JAYTHARI Oral Suspension
- Product NDC
- 70710-2131
- 11-digit product format
- 707102131
- Labeler code
- 70710
- Product ID
- 70710-2131_726f1539-369c-4fc4-a1fe-059457d26c49
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deflazacort
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Application
- ANDA220042
- Marketing category
- ANDA
- Marketing start
- 2025-11-20
- Substance
- DEFLAZACORT
- Active strength
- 22.75 mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- JAYTHARI Oral Suspension
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DEFLAZACORT | 22.75 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KR5YZ6AE4B |
| Rxcui | 1870964, 2727381 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70710-2131-3 | JAYTHARI Oral Suspension | 1 in 1 CARTON | SUSPENSION | 1 | | 1 |
| 70710-2131-3 | JAYTHARI Oral Suspension | 13 mL in 1 BOTTLE | SUSPENSION | 13 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70710-2131-3 | 70710213103 | 1 BOTTLE in 1 CARTON (70710-2131-3) / 13 mL in 1 BOTTLE | 1 bottle | 2025-11-20 | No | No | Current |